![Ken Coyle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ken Coyle
Profile
Ken Coyle served as the Chief Executive Officer at Genactis, Inc. He also worked as the Senior Director-Respiratory Biologics Marketing at AstraZeneca PLC and as the Vice President-Sales at Radius Health, Inc. Coyle holds a graduate degree from Rutgers State University of New Jersey and an undergraduate degree from Grinnell College.
Former positions of Ken Coyle
Companies | Position | End |
---|---|---|
ASTRAZENECA PLC | Sales & Marketing | - |
Genactis, Inc. | Chief Executive Officer | - |
RADIUS HEALTH, INC. | Sales & Marketing | - |
Training of Ken Coyle
Rutgers State University of New Jersey | Graduate Degree |
Grinnell College | Undergraduate Degree |
Experiences
Positions held
Linked companies
Listed companies | 1 |
---|---|
ASTRAZENECA PLC | Health Technology |
Private companies | 2 |
---|---|
Radius Health, Inc.
![]() Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Genactis, Inc. |
- Stock Market
- Insiders
- Ken Coyle